US 7981618
Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer
granted A61PA61P35/00
Quick answer
US patent 7981618 (Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer) held by The Board of Regents of the University of Texas System expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jul 19 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00